# A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)

> **NCT00132717** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 450 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** MK0653A (ezetimibe [+] simvastatin)
- **DRUG:** Comparator: atorvastatin
- **DRUG:** Comparator: fluvastatin
- **DRUG:** Comparator: lovastatin
- **DRUG:** Comparator: pravastatin
- **DRUG:** Comparator: rosuvastatin
- **DRUG:** Comparator: simvastatin

## Key facts

- **NCT ID:** NCT00132717
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01-01
- **Primary completion:** 2007-06-01
- **Final completion:** 2007-06-01
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00132717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00132717, "A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00132717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*